Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2010.6000
-9.50
(
-0.47
%)
NSE
Dec 26, 2025
15:31 PM
57.63% Gain from 52W Low
Volume:
206.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
14 Aug 2023
2010.60
-0.47%
EU/ROW markets and operating leverage drive profitability
Neutral:
Glenmark Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 780
Target
Motilal Oswal
Glenmark Pharmaceuticals Ltd. is trading above all available SMAs
More from Glenmark Pharmace…
All earning calls
Investor presentations from Glenmark Pharmace…
All investor presentations